These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 24136889)
1. Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer. Liu D; Yang C; Bojdani E; Murugan AK; Xing M J Natl Cancer Inst; 2013 Nov; 105(21):1617-27. PubMed ID: 24136889 [TBL] [Abstract][Full Text] [Related]
2. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer. Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574 [TBL] [Abstract][Full Text] [Related]
3. RASAL1 in thyroid cancer: wisdom from an old foe. Ngeow J; Eng C J Natl Cancer Inst; 2013 Nov; 105(21):1597-9. PubMed ID: 24136888 [No Abstract] [Full Text] [Related]
4. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors. Hou P; Ji M; Xing M Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514 [TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Xing M Thyroid; 2010 Jul; 20(7):697-706. PubMed ID: 20578891 [TBL] [Abstract][Full Text] [Related]
6. RASAL1 in thyroid cancer: promise from a new friend. Xing M J Clin Endocrinol Metab; 2014 Oct; 99(10):3619-21. PubMed ID: 25226296 [No Abstract] [Full Text] [Related]
7. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma. Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058 [TBL] [Abstract][Full Text] [Related]
8. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. Liu Z; Hou P; Ji M; Guan H; Studeman K; Jensen K; Vasko V; El-Naggar AK; Xing M J Clin Endocrinol Metab; 2008 Aug; 93(8):3106-16. PubMed ID: 18492751 [TBL] [Abstract][Full Text] [Related]
9. Molecular perspectives in differentiated thyroid cancer. Buffet C; Groussin L Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S8-15. PubMed ID: 26826484 [TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. Santarpia L; El-Naggar AK; Cote GJ; Myers JN; Sherman SI J Clin Endocrinol Metab; 2008 Jan; 93(1):278-84. PubMed ID: 17989125 [TBL] [Abstract][Full Text] [Related]
11. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Hou P; Liu D; Shan Y; Hu S; Studeman K; Condouris S; Wang Y; Trink A; El-Naggar AK; Tallini G; Vasko V; Xing M Clin Cancer Res; 2007 Feb; 13(4):1161-70. PubMed ID: 17317825 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247 [TBL] [Abstract][Full Text] [Related]
13. High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors. Wang Y; Hou P; Yu H; Wang W; Ji M; Zhao S; Yan S; Sun X; Liu D; Shi B; Zhu G; Condouris S; Xing M J Clin Endocrinol Metab; 2007 Jun; 92(6):2387-90. PubMed ID: 17426084 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer. Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515 [TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403 [TBL] [Abstract][Full Text] [Related]
16. Reduced expression of RAS protein activator like-1 in gastric cancer. Seto M; Ohta M; Ikenoue T; Sugimoto T; Asaoka Y; Tada M; Mohri D; Kudo Y; Ijichi H; Tateishi K; Otsuka M; Hirata Y; Maeda S; Koike K; Omata M Int J Cancer; 2011 Mar; 128(6):1293-302. PubMed ID: 20473946 [TBL] [Abstract][Full Text] [Related]
17. Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice. Li S; Li P; Liu W; Shang J; Qiu S; Li X; Liu W; Shi H; Zhou M; Liu H Oxid Med Cell Longev; 2020; 2020():3158108. PubMed ID: 33456666 [TBL] [Abstract][Full Text] [Related]
18. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways. Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152 [TBL] [Abstract][Full Text] [Related]
19. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area. Jeon MJ; Chun SM; Kim D; Kwon H; Jang EK; Kim TY; Kim WB; Shong YK; Jang SJ; Song DE; Kim WG Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298 [TBL] [Abstract][Full Text] [Related]
20. Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors. Joseph B; Ji M; Liu D; Hou P; Xing M J Clin Endocrinol Metab; 2007 Dec; 92(12):4766-70. PubMed ID: 17911173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]